KEYTRUDA (pembrolizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** PEMBROLIZUMAB

**Strength:** 25 mg/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Merck Sharp & Dohme LLC

**Marketing category:** BLA (BLA125514)

**Pharmacologic class:** Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]